13/12/2022

EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
08/12/2022

‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

06/10/2022

EuropaBio celebrates its inaugural Healthcare BioForum

30/09/2022

Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe

25/09/2022

European Biotech Week 2022 starts today!

07/09/2022

Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine

07/09/2022

Factsheet – European Health Data Space

07/09/2022

Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

07/09/2022

Factsheet – A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe